Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' FREEDMAN RS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 77 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ferrandina, G; Filippini, P; Ferlini, C; Maggiano, N; Stoler, AB; Fruscella, E; Mozzetti, S; Mancuso, S; Freedman, RS; Scambia, G; Ranelletti, FO
      Growth inhibitory effects and radiosensitization induced by fatty aromaticacids on human cervical cancer cells

      ONCOLOGY RESEARCH
    2. Azevedo, P; Verschraegen, CF; Kavanagh, JJ; Kudelka, AP; Freedman, RS; Lu, K; Deavers, MT
      Malignant mixed mesodermal tumor of the ovary treated with a cisplatin-irinotecan combination: case report

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    3. Zavadova, E; Savary, CA; Templin, S; Verschraegen, CF; Freedman, RS
      Maturation of dendritic cells from ovarian cancer patients

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    4. Hosing, C; Freedman, RS; McLaughlin, P; Malpica, A; Fornage, BD; Kudelka, AP
      Diffuse large B-cell non-Hodgkin's lymphoma presenting as a vaginal mass in a patient with a history of intestinal mucosa-associated lymphoid tissue (MALT) lymphoma

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    5. Donato, ML; Gershenson, DM; Wharton, JT; Ippoliti, CM; Aleman, AS; Bodurka-Bevers, D; Bevers, MW; Burke, TW; Levenback, CF; Wolf, JK; Freedman, RS; Bast, RC; Gajewski, JL; Champlin, RE
      High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: A new regimen for the treatment of advanced ovarian cancer

      GYNECOLOGIC ONCOLOGY
    6. Ramirez, PT; Freedman, RS
      Gynecologic problems in patients with breast cancer

      BREAST CANCER
    7. Borchardt, PE; Quadri, SM; Freedman, RS; Vriesendorp, HM
      Intraperitoneal radioimmunotherapy with human monoclonal IGM in nude mice with peritoneal carcinomatosis

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    8. Freedman, RS; Kudelka, AP; Kavanagh, JJ; Verschraegen, C; Edwards, CL; Nash, M; Levy, L; Atkinson, EN; Zhang, HZ; Melichar, B; Patenia, R; Templin, S; Scott, W; Platsoucas, CD
      Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma

      CLINICAL CANCER RESEARCH
    9. Hu, W; Wu, WG; Nash, MA; Freedman, RS; Kavanagh, JJ; Verschraegen, CF
      Anomalies of the TGF-beta postreceptor signaling pathway in ovarian cancercell lines

      ANTICANCER RESEARCH
    10. Melichar, B; Nash, MA; Lenzi, R; Platsoucas, CD; Freedman, RS
      Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3(+) tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    11. Saumon, D; Geballe, TR; Leggett, SK; Marley, MS; Freedman, RS; Lodders, K; Fegley, B; Sengupta, SK
      Molecular abundances in the atmosphere of the T dwarf G1 229B

      ASTROPHYSICAL JOURNAL
    12. Vadhan-Raj, S; Verschraegen, CF; Bueso-Ramos, C; Broxmeyer, HE; Kudelka, AP; Freedman, RS; Edwards, CL; Gershenson, D; Jones, D; Ashby, M; Kavanagh, JJ
      Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer

      ANNALS OF INTERNAL MEDICINE
    13. Nash, MA; Ferrandina, G; Gordinier, M; Loercher, A; Freedman, RS
      The role of cytokines in both the normal and malignant ovary

      ENDOCRINE-RELATED CANCER
    14. Gordinier, ME; Zhang, HZ; Patenia, R; Levy, LB; Atkinson, EN; Nash, MA; Katz, RL; Platsoucas, CD; Freedman, RS
      Quantitative analysis of transforming growth factor beta 1 and 2 in ovarian carcinoma

      CLINICAL CANCER RESEARCH
    15. Kudelka, AP; Verschraegen, CF; Shen, Y; De Leon, CG; Edwards, CL; Freedman, RS; Forman, A; Gibbs, HR; Mante, R; Hord, M; Canetta, R; Krakoff, I; Kavanagh, JJ
      Long-term results and pharmacokinetics of high-dose paclitaxel in patientswith refractory epithelial ovarian carcinoma

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    16. Verschraegen, CF; Gupta, F; Loyer, E; Kavanagh, JJ; Kudelka, AP; Freedman, RS; Edwards, CL; Harris, N; Steger, M; Steltz, V; Giovanella, BC; Stehlin, JS
      A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer

      ANTI-CANCER DRUGS
    17. Zavadova, E; Loercher, A; Verstovsek, S; Verschraegen, CE; Micksche, M; Freedman, RS
      The role of macrophages in antitumor defense of patients with ovarian cancer

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    18. Loercher, AE; Nash, MA; Kavanagh, JJ; Platsoucas, CD; Freedman, RS
      Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells

      JOURNAL OF IMMUNOLOGY
    19. Nash, MA; Loercher, AE; Freedman, RS
      In vitro growth inhibition of ovarian cancer cells by decorin: Synergism of action between decorin and carboplatin

      CANCER RESEARCH
    20. Sromovsky, LA; Collard, AD; Fry, PM; Orton, GS; Lemmon, MT; Tomasko, MG; Freedman, RS
      Galileo probe measurements of thermal and solar radiation fluxes in the Jovian atmosphere

      JOURNAL OF GEOPHYSICAL RESEARCH-PLANETS
    21. BORCHARDT PE; VRIESENDORP HM; FREEDMAN RS; QUADRI SM
      INTRACOMPARTMENTAL ADMINISTRATION OF RADIOLABELED HUMAN-IGM

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    22. MELICHAR B; SAVARY C; KUDELKA AP; VERSCHRAEGEN C; KAVANAGH JJ; EDWARDS CL; PLATSOUCAS CD; FREEDMAN RS
      LINEAGE-NEGATIVE HUMAN-LEUKOCYTE ANTIGEN-DR+ CELLS WITH THE PHENOTYPEOF UNDIFFERENTIATED DENDRITIC CELLS IN PATIENTS WITH CARCINOMA OF THEABDOMEN AND PELVIS

      Clinical cancer research
    23. MELICHAR B; SAVARY C; KUDELKA AP; VERSCHRAEGEN C; KAVANAGH JJ; EDWARDS CL; PLATSOUCAS CD; FREEDMAN RS
      LINEAGE-NEGATIVE HUMAN-LEUKOCYTE ANTIGEN-DR+ CELLS WITH THE PHENOTYPEOF UNDIFFERENTIATED DENDRITIC CELLS IN PATIENTS WITH CARCINOMA OF THEABDOMEN AND PELVIS

      Clinical cancer research
    24. Melichar, B; Ferrandina, G; Verschraegen, CF; Loercher, A; Abbruzzese, JL; Freedman, RS
      Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell lines

      CLINICAL CANCER RESEARCH
    25. Verschraegen, CF; Kudelka, AP; Loyer, E; Edwards, CL; Freedman, RS; Kavanagh, JJ
      A phase II trial of high-dose hydroxyurea administered parenterally in patients with epithelial ovarian carcinoma refractory to platinum

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    26. KUDELKA AP; HASENBURG A; VERSCHRAEGEN CF; EDWARDS CL; MEYERS CA; VARMA D; FREEDMAN RS; FORMAN A; CONRAD CA; GROVE W; GROTHEY A; KAVANAGH JJ
      PHASE-II STUDY OF IV CL-980 IN PATIENTS WITH ADVANCED PLATINUM REFRACTORY EPITHELIAL OVARIAN-CARCINOMA

      Anti-cancer drugs
    27. VERSCHRAEGEN CF; NATELSON EA; GIOVANELLA BC; KAVANAGH JJ; KUDELKA AP; FREEDMAN RS; EDWARDS CL; ENDE K; STEHLIN JS
      A PHASE-I CLINICAL AND PHARMACOLOGICAL STUDY OF ORAL 9-NITROCAMPTOTHECIN, A NOVEL WATER-INSOLUBLE TOPOISOMERASE-I INHIBITOR

      Anti-cancer drugs
    28. JUNG WJ; PAPPAS J; HELM CW; FREEDMAN RS; PLATSOUCAS CD
      GAMMA-CHAIN T-CELL RECEPTOR (TCR) TRANSCRIPTS IN SOLID TUMOR SPECIMENS AND PERIPHERAL-BLOOD FROM PATIENTS WITH EPITHELIAL OVARIAN-CARCINOMA(EOC) ARE CLONALLY EXPANDED

      The FASEB journal
    29. KUDELKA AP; LENZI R; ATKINSON EN; LEVY LB; FREEDMAN RS
      IS ASCITIC FLUID INTERLEUKIN-12 AN INDEPENDENT PROGNOSTIC FACTOR IN OVARIAN-CANCER - THE NECESSITY OF CORRECTION MILLIGRAM P VALUES FOR MULTIPLE COMPARISONS

      Journal of clinical oncology
    30. SAVARY CA; GRAZZIUTTI ML; MELICHAR B; PRZEPIORKA D; FREEDMAN RS; COWART RE; COHEN DM; ANAISSIE EJ; WOODSIDE DG; MCINTYRE BW; PIERSON DL; PELLIS NR; REX JH
      MULTIDIMENSIONAL FLOW-CYTOMETRIC ANALYSIS OF DENDRITIC CELLS IN PERIPHERAL-BLOOD OF NORMAL DONORS AND CANCER-PATIENTS

      Cancer immunology and immunotherapy
    31. BORCHARDT PE; QUADRI SM; FREEDMAN RS; VRIESENDORP HM
      INDIUM-111-LABELED AND YTTRIUM-90-LABELED HUMAN MONOCLONAL IMMUNOGLOBULIN-M TARGETING OF HUMAN OVARIAN-CANCER IN MICE

      The Journal of nuclear medicine
    32. CHACKERIAN C; FREEDMAN RS; GIVER LP; BROWN LR
      THE NO VIBRATIONAL FUNDAMENTAL-BAND - O-2-BROADENING COEFFICIENTS

      Journal of molecular spectroscopy (Print)
    33. NASH MA; LENZI R; PLATSOUCAS CD; FREEDMAN RS
      RT-PCR QUANTITATION OF CYTOKINE RESPONSES IN-VIVO FROM SPECIMENS CONTAINING SMALL NUMBERS OF CELLS DURING BIOIMMUNOTHERAPY

      Journal of immunological methods
    34. NASH MA; LENZI R; EDWARDS CL; KAVANAGH JJ; KUDELKA AP; VERSCHRAEGEN CF; PLATSOUCAS CD; FREEDMAN RS
      DIFFERENTIAL EXPRESSION OF CYTOKINE TRANSCRIPTS IN HUMAN EPITHELIAL OVARIAN-CARCINOMA BY SOLID TUMOR SPECIMENS, PERITONEAL-EXUDATE CELLS CONTAINING TUMOR, TUMOR-INFILTRATING LYMPHOCYTE (TIL)-DERIVED T-CELL LINES AND ESTABLISHED TUMOR-CELL LINES

      Clinical and experimental immunology
    35. FREEDMAN RS; LENZI R; KUDELKA AP; LAWRENCE DD; ROSENBLUM M; PLATSOUCAS CD
      INTRAPERITONEAL IMMUNOTHERAPY OF PERITONEAL CARCINOMATOSIS

      Cytokines cellular & molecular therapy
    36. KUDELKA AP; LEVY T; VERSCHRAEGEN CF; EDWARDS CL; PIAMSOMBOON S; TERMRUNGRUANGLERT W; FREEDMAN RS; KAPLAN AL; KIEBACK DG; MEYERS CA; JAECKLE KA; LOYER E; STEGER M; MANTE R; MAVLIGIT G; KILLIAN A; TANG RA; GUTTERMAN JU; KAVANAGH JJ
      A PHASE-I STUDY OF TNP-470 ADMINISTERED TO PATIENTS WITH ADVANCED SQUAMOUS-CELL CANCER OF THE CERVIX

      Clinical cancer research
    37. HUBBARD WB; GUILLOT T; LUNINE JI; BURROWS A; SAUMON D; MARLEY MS; FREEDMAN RS
      LIQUID METALLIC HYDROGEN AND THE STRUCTURE OF BROWN DWARFS AND GIANT PLANETS

      Physics of plasmas
    38. KUDELKA AP; SIDDIK ZH; TRESUKOSOL D; EDWARDS CL; FREEDMAN RS; MADDEN TL; RASTOGI R; HORD M; KIM EE; TORNOS C; MANTE R; KAVANAGH JJ
      A PHASE-II AND PHARMACOKINETIC STUDY OF ENLOPLATIN IN PATIENTS WITH PLATINUM REFRACTORY ADVANCED OVARIAN-CARCINOMA

      Anti-cancer drugs
    39. KUDELKA AP; WINN R; EDWARDS CL; DOWNEY G; GREENBERG H; DAKHIL SR; FREEDMAN RS; LOCOCO S; UMBREIT J; DELMORE JE; ARBUCK S; LOYER E; GACRAMA P; FUEGER R; KAVANAGH JJ
      AN UPDATE OF A PHASE-II STUDY OF PACLITAXEL IN ADVANCED OR RECURRENT SQUAMOUS-CELL CANCER OF THE CERVIX

      Anti-cancer drugs
    40. VERSCHRAEGEN CF; LEVY T; KUDELKA AP; LLERENA E; ENDE K; FREEDMAN RS; EDWARDS CL; HORD M; STEGER M; KAPLAN AL; KIEBACK D; FISHMAN A; KAVANAGH JJ
      PHASE-II STUDY OF IRINOTECAN IN PRIOR CHEMOTHERAPY-TREATED SQUAMOUS-CELL CARCINOMA OF THE CERVIX

      Journal of clinical oncology
    41. BORCHARDT PE; QUADRI SM; FREEDMAN RS; VRIESENDORP HM
      INTRALESIONAL RADIOLABELED HUMAN MONOCLONAL IGM IN HUMAN TUMOR XENOGRAFTS

      Radiotherapy and oncology
    42. FERRANDINA G; MELICHAR B; LOERCHER A; VERSCHRAEGEN CF; KUDELKA AP; EDWARDS CL; SCAMBIA G; KAVANAGH JJ; ABBRUZZESE JL; FREEDMAN RS
      GROWTH-INHIBITORY EFFECTS OF SODIUM PHENYLACETATE (NSC-3039) ON OVARIAN-CARCINOMA CELLS IN-VITRO

      Cancer research
    43. KUDELKA AP; WINN R; EDWARDS CL; DOWNEY G; GREENBERG H; DAKHIL SR; FREEDMAN RS; LOYER E; RUSINKIEWICZ J; GACRAMA F; FUEGER R; KAVANAGH JJ
      ACTIVITY OF PACLITAXEL IN ADVANCED OR RECURRENT SQUAMOUS-CELL CANCER OF THE CERVIX

      Clinical cancer research
    44. KAVANAGH JJ; KUDELKA AP; DELEON CG; TRESUKOSOL D; HORD M; FINNEGAN MB; KIM EE; VARMA D; FORMAN A; COHEN P; EDWARDS CL; FREEDMAN RS; VERSCHRAEGEN CF
      PHASE-II STUDY OF DOCETAXEL IN PATIENTS WITH EPITHELIAL OVARIAN-CARCINOMA REFRACTORY TO PLATINUM

      Clinical cancer research
    45. FREEDMAN RS; GIBBONS JA; GIEDLIN M; KUDELKA AP; KAVANAGH JJ; EDWARDS CL; CARRASCO CH; NASH MA; PLATSOUCAS CD
      IMMUNOPHARMACOLOGY AND CYTOKINE PRODUCTION OF A LOW-DOSE SCHEDULE OF INTRAPERITONEALLY ADMINISTERED HUMAN RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CARCINOMA

      Journal of immunotherapy with emphasis on tumor immunology
    46. LOPEZ A; TESSADRELLI A; KUDELKA AP; EDWARDS CL; FREEDMAN RS; HORD M; KAVANAGH JJ
      COMBINATION THERAPY WITH LEUPROLIDE ACETATE AND TAMOXIFEN IN REFRACTORY OVARIAN-CANCER

      International journal of gynecological cancer
    47. FREEDMAN RS; PLASTOUCAS CD; DEISSEROTH AB
      USE OF A RETROVIRAL VECTOR TO STUDY THE TRAFFICKING PATTERNS OF PURIFIED OVARIAN TUMOR-INFILTRATING LYMPHOCYTES (TIL) USED IN INTRAPERITONEAL ADOPTIVE IMMUNOTHERAPY OF OVARIAN-CANCER PATIENTS - A PILOT-STUDY

      Human gene therapy
    48. VERSCHRAEGEN CF; KUDELKA AP; TERMRUNGRUANGLERT W; DELEON CG; EDWARDS CL; FREEDMAN RS; KAVANAGH JJ; VADHANRAJ S
      EFFECTS OF INTERLEUKIN-1-ALPHA ON OVARIAN-CARCINOMA IN PATIENTS WITH RECURRENT DISEASE

      European journal of cancer
    49. PIAMSOMBOON S; TERMRUNGRUANGLERT W; KUDELKA AP; EDWARDS CL; FREEDMAN RS; MOUNTAIN CF; DELCLOS L; AAPRO MS; DECARO L; BIANCA J; VERSCHRAEGEN CF; KAVANAGH JJ
      PROLONGED STABILIZATION OF PROGRESSIVE SQUAMOUS-CELL CANCER OF THE CERVIX WITH INTERFERON-ALPHA AND 13-CIS-RETINOIC ACID - REPORT OF 2 CASES AND REVIEW OF THE LITERATURE

      Anti-cancer drugs
    50. KUDELKA AP; VERSCHRAEGEN CF; LEVY T; EDWARDS CL; FISHMAN A; FREEDMAN RS; KAPLAN A; KIEBACK DG; MANTE R; ENDE K; STEGER M; KAVANAGH JJ
      PRELIMINARY-REPORT OF THE ACTIVITY OF DOCETAXEL IN ADVANCED OR RECURRENT SQUAMOUS-CELL CANCER OF THE CERVIX

      Anti-cancer drugs
    51. FREEDMAN RS; TORTOLEROLUNA G; PANDEY DK; MALPICA A; BAKER VV; WHITTAKER L; JOHNSON E; MITCHELL MF
      GESTATIONAL TROPHOBLASTIC DISEASE

      Obstetrics and gynecology clinics of North America
    52. FREEDMAN RS; DIGIORGIO R
      ASSESSING ALTERNATIVE TECHNOLOGIES FOR THE COST-EFFECTIVE COMPUTATIONOF DERIVATIVES

      Applied artificial intelligence
    53. KUDELKA AP; TRESUKOSOL D; EDWARDS CL; FREEDMAN RS; LEVENBACK C; CHANTARAWIROJ P; DELEON CG; KIM EE; MADDEN T; WALLIN B; HORD M; VERSCHRAEGEN C; RABER M; KAVANAGH JJ
      PHASE-II STUDY OF INTRAVENOUS TOPOTECAN AS A 5-DAY INFUSION FOR REFRACTORY EPITHELIAL OVARIAN-CARCINOMA

      Journal of clinical oncology
    54. BURROWS A; HUBBARD WB; LUNINE JI; GUILLOT T; SAUMON D; MARLEY M; FREEDMAN RS
      THEORETICAL-MODELS OF EXTRASOLAR GIANT PLANETS

      Nuclear physics. B
    55. VRIESENDORP HM; QUADRI SM; JAECKLE KA; FREEDMAN RS; CROMEENS DM
      PROPOSAL FOR TRANSLATIONAL ANALYSIS AND DEVELOPMENT OF CLINICAL RADIOLABELED IMMUNOGLOBULIN THERAPY

      Radiotherapy and oncology
    56. QUADRI SM; MALIK AB; CHU HB; FREEDMAN RS; VRIESENDORP HM
      INTRAPERITONEAL INDIUM-111-LABELED AND YTTRIUM-90-LABELED HUMAN-IGM (AC6C3-2B12) IN NUDE-MICE BEARING PERITONEAL CARCINOMATOSIS

      The Journal of nuclear medicine
    57. MARLEY MS; SAUMON D; GUILLOT T; FREEDMAN RS; HUBBARD WB; BURROWS A; LUNINE JI
      ATMOSPHERIC, EVOLUTIONARY, AND SPECTRAL MODELS OF THE BROWN DWARF GLIESE-229-B

      Science
    58. SROMOVSKY LA; BEST FA; COLLARD AD; FRY PM; REVERCOMB HE; FREEDMAN RS; ORTON GS; HAYDEN JL; TOMASKO MG; LEMMON MT
      SOLAR AND THERMAL-RADIATION IN JUPITER ATMOSPHERE - INITIAL RESULTS OF THE GALILEO PROBE NET FLUX RADIOMETER

      Science
    59. FISHMAN A; KUDELKA AP; TRESUKOSOL D; EDWARDS CL; FREEDMAN RS; KAPLAN AL; GIRTANNER RE; KAVANAGH JJ
      LEUPROLIDE ACETATE FOR TREATING REFRACTORY OR PERSISTENT OVARIAN GRANULOSA-CELL TUMOR

      Journal of reproductive medicine
    60. KOOI S; ZHANG HZ; PATENIA R; EDWARDS CL; PLATSOUCAS CD; FREEDMAN RS
      HLA CLASS-I EXPRESSION ON HUMAN OVARIAN-CARCINOMA CELLS CORRELATES WITH T-CELL INFILTRATION IN-VIVO AND T-CELL EXPANSION IN-VITRO IN LOW CONCENTRATIONS OF RECOMBINANT INTERLEUKIN-2

      Cellular immunology
    61. KAVANAGH JJ; TRESUKOSOL D; DELEON CG; EDWARDS CL; FREEDMAN RS; HORD M; HOWELL E; LENZI R; KRAKOFF IH; KUDELKA AP
      PHASE-II STUDY OF PROLONGED ORAL ETOPOSIDE IN REFRACTORY OVARIAN-CANCER

      International journal of gynecological cancer
    62. KASI LP; LAMKI LM; SARANTI S; PODOLOFF DA; FREEDMAN RS
      IN-111 LABELED LEUKOCYTES IN EVALUATION OF ACTIVE SPECIFIC IMMUNOTHERAPY RESPONSES

      International journal of gynecological cancer
    63. NASH MA; PLATSOUCAS CD; WONG BY; WONG PMC; COTTLERFOX M; OTTO E; FREEDMAN RS
      TRANSDUCTION OF RIL-2 EXPANDED CD4(-DERIVED T-CELL LINES WITH THE G1NA (NEO(R)) REPLICATION-DEFICIENT RETROVIRAL VECTOR() AND CD8(+) OVARIAN TIL)

      Human gene therapy
    64. KAVANAGH JJ; EDWARDS CL; FREEDMAN RS; FINNEGAN MB; BALAT O; TRESUKOSOL D; BURK K; LOECHNER S; HORD M; FRANKLIN JL; KUDELKA AP
      A TRIAL OF LOBAPLATIN (D-19466) IN PLATINUM-RESISTANT OVARIAN-CANCER

      Gynecologic oncology
    65. QUADRI SM; MALIK AB; TANG XZ; PATENIA R; FREEDMAN RS; VRIESENDORP HM
      PRECLINICAL ANALYSIS OF INTRAPERITONEAL ADMINISTRATION OF IN-111-LABELED HUMAN TUMOR REACTIVE MONOCLONAL IGM AC6C3-2B12

      Cancer research
    66. FREEDMAN RS; EDWARDS CL; KAVANAGH JJ; KUDELKA AP; KATZ RL; CARRASCO CH; ATKINSON EN; SCOTT W; TOMASOVIC B; TEMPLIN S; PLATSOUCAS CD
      INTRAPERITONEAL ADOPTIVE IMMUNOTHERAPY OF OVARIAN-CARCINOMA WITH TUMOR-INFILTRATING LYMPHOCYTES AND LOW-DOSE RECOMBINANT INTERLEUKIN-2 - A PILOT TRIAL

      Journal of immunotherapy with emphasis on tumor immunology
    67. INSKIP PD; EBY NL; COOKFAIR D; FREEDMAN RS; RICHARDSON GS; WACTAWSKIWENDE J; HOOVER RN; BOICE JD
      SERUM ESTROGEN AND ANDROGEN LEVELS FOLLOWING TREATMENT FOR CERVICAL-CANCER

      Cancer epidemiology, biomarkers & prevention
    68. FREEDMAN RS; BOWEN JM; DELCOS L; EDWARDS CL; WALLACE S; ATKINSON EN; IOANNIDES CG; KASI LP; SCOTT W; PATENIA R
      ACTIVE INTRALYMPHATIC IMMUNOTHERAPY OF UTERINE CERVICAL-CARCINOMA WITH VIRAL ONCOLYSATE - A PILOT-STUDY

      International journal of gynecological cancer
    69. VADHANRAJ S; KUDELKA AP; GARRISON L; GANO J; EDWARDS CL; FREEDMAN RS; KAVANAGH JJ
      EFFECTS OF INTERLEUKIN-1-ALPHA ON CARBOPLATIN-INDUCED THROMBOCYTOPENIA IN PATIENTS WITH RECURRENT OVARIAN-CANCER

      Journal of clinical oncology
    70. COLEMAN RL; KEENEY ED; FREEDMAN RS; BURKE TW; EIFEL PJ; RUTLEDGE FN
      RADICAL HYSTERECTOMY FOR RECURRENT CARCINOMA OF THE UTERINE CERVIX AFTER RADIOTHERAPY

      Gynecologic oncology
    71. COLEMAN RL; KEENEY ED; FREEDMAN RS; BURKE TW; EIFEL PJ; RUTLEDGE FN
      RADICAL HYSTERECTOMY FOR RECURRENT CARCINOMA OF THE UTERINE CERVIX AFTER RADIOTHERAPY

      Gynecologic oncology
    72. FREEDMAN RS; TOMASOVIC B; TEMPLIN S; ATKINSON EN; KUDELKA A; EDWARDS CL; PLATSOUCAS CD
      LARGE-SCALE EXPANSION IN INTERLEUKIN-2 OF TUMOR-INFILTRATING LYMPHOCYTES FROM PATIENTS WITH OVARIAN-CARCINOMA FOR ADOPTIVE IMMUNOTHERAPY

      Journal of immunological methods
    73. KOOI S; FREEDMAN RS; RODRIGUEZVILLANUEVA J; PLATSOUCAS CD
      CYTOKINE PRODUCTION BY T-CELL LINES DERIVED FROM TUMOR-INFILTRATING LYMPHOCYTES FROM PATIENTS WITH OVARIAN-CARCINOMA - TUMOR-SPECIFIC IMMUNE-RESPONSES AND INHIBITION OF ANTIGEN-INDEPENDENT CYTOKINE PRODUCTION BY OVARIAN TUMOR-CELLS

      Lymphokine and cytokine research
    74. KUDELKA AP; FREEDMAN RS; EDWARDS CL; LIPPMAN SM; TORNOS CS; KRAKOFF IH; KAVANAGH JJ
      METASTATIC ADENOCARCINOMA OF THE ENDOMETRIUM TREATED WITH 13-CIS-RETINOIC ACID PLUS INTERFERON-ALPHA

      Anti-cancer drugs
    75. KOOI S; FREEDMAN RS; PLATSOUCAS CD
      CYTOKINE PRODUCTION BY T-CELL LINES DERIVED FROM TUMOR-INFILTRATING LYMPHOCYTES (TIL) FROM PATIENTS WITH OVARIAN-CARCINOMA - TUMOR-SPECIFICRESPONSES AND INHIBITION OF SPONTANEOUS CYTOKINE PRODUCTION BY TUMOR-CELLS

      The Journal of immunology
    76. LIN WL; CHEN PF; FREEDMAN RS; PLATSOUCAS CD
      FRESH (UNCULTURED) TUMOR-INFILTRATING LYMPHOCYTES (TIL) FROM PATIENTSWITH MALIGNANT-MELANOMA OR OVARIAN-CARCINOMA ARE COMPRISED OF OLIGOCLONAL T-CELLS

      The Journal of immunology
    77. FREEDMAN RS; EDWARDS CL; KAVANAGH J; KUDELKA A; SCOTT W; TOMASOVIC B; TEMPLIN S; PLATSOUCAS CD
      ADOPTIVE IMMUNOTHERAPY OF PATIENTS WITH ADVANCED OVARIAN-CARCINOMA WITH RIL2-EXPANDED TUMOR INFILTRATING LYMPHOCYTES (TIL) PLUS LOW-DOSE OFRIL2

      The Journal of immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 18:29:33